MiniMed Group, Inc. (MMED) Stock Analysis & Investment Frameworks
MiniMed Group, Inc. (MMED) stock analysis on Invetso. Review MiniMed Group, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
MiniMed Group, Inc. Company Overview
- Exchange: NASDAQ Global Select
- Sector: Healthcare
- Industry: Medical - Equipment & Services
- Country: US
MiniMed Group, Inc. Key Financial Metrics
- Market Cap: $5.11B
- Revenue: $3.10B
- ROE: -9.11%
- ROIC: 0.43%
- Dividend Yield: N/A
About MiniMed Group, Inc.
MiniMed Group, Inc. specializes in designing, producing, and distributing a broad spectrum of medical technologies and solutions aimed at effective diabetes management. The company's diverse portfolio features essential tools like insulin pumps, continuous glucose monitoring (CGM) systems, infusion sets, specialized software platforms, and various supplementary accessories. These innovations are crafted to enable both patients and healthcare providers to accurately monitor and precisely regulate blood glucose levels. The enterprise was established in 1983 by Alfred E. Mann and is currently headquartered in Northridge, California.